Company Filing History:
Years Active: 2002
Title: Olivier Freund: Innovator in Nucleic Acid Compositions
Introduction
Olivier Freund is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of biotechnology, particularly in the development of compositions that incorporate nucleic acids. His work has implications for pharmaceuticals, especially in gene therapy.
Latest Patents
Olivier Freund holds 1 patent for a composition that contains a plurality of multicellular vesicles and at least one nucleic acid. This innovative composition features multilamellar vesicles, which are formed from concentric bi-layers that include at least one surfactant agent. The bi-layers are separated by a liquid medium, allowing for effective delivery of nucleic acids. Such compositions are particularly useful in pharmaceutics, including applications in gene therapy and transfection, both in vitro and in vivo.
Career Highlights
Freund is associated with Capsulis, a company that focuses on advanced biotechnological solutions. His work at Capsulis has positioned him as a key player in the development of novel therapeutic approaches using nucleic acid compositions.
Collaborations
Olivier Freund has collaborated with notable colleagues such as Patrick Mahy and Didier Roux. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Olivier Freund's innovative work in nucleic acid compositions showcases his commitment to advancing biotechnology. His contributions have the potential to significantly impact the field of gene therapy and pharmaceutical applications.